Mitsubishi UFJ Trust & Banking’s Novavax NVAX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$291K	Sell	30,879 -75,628	-71%	-$678K	﹤0.01%	1220
2026 Q1	$867K	Buy	106,507 +17,325	+19%	+$157K	﹤0.01%	920
2025 Q4	$599K	Buy	89,182 +55,110	+162%	+$415K	﹤0.01%	955
2025 Q3	$295K	Sell	34,072 -33,649	-50%	-$262K	﹤0.01%	1027
2025 Q2	$427K	Buy	+67,721	New	+$448K	﹤0.01%	918
2022 Q2	–	Sell	-34,105	Closed	-$2.51M	–	1278
2022 Q1	$2.51M	Sell	34,105 -2,020	-6%	-$180K	0.01%	778
2021 Q4	$5.17M	Sell	36,125 -4,162	-10%	-$715K	0.01%	728
2021 Q3	$8.35M	Sell	40,287 -264	-0.7%	-$58.2K	0.02%	641
2021 Q2	$8.61M	Buy	+40,551	New	+$7.43M	0.02%	650

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's NVAX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking reduced its Novavax (NVAX) stake by 71% in Q2 2026, selling an estimated $678K and leaving 30,879 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Mitsubishi UFJ Trust & Banking first reported a position in NVAX in Q2 2021 and has held it in 9 quarters since. The position peaked at $8.61M in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 30,879 shares of Novavax worth $291K as of Q2 2026.
Mitsubishi UFJ Trust & Banking sold 75,628 Novavax shares in Q2 2026, an estimated $678K.
Novavax made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1220 holding.
Mitsubishi UFJ Trust & Banking first reported a position in Novavax in Q2 2021 and has held it in 9 quarters since.
Mitsubishi UFJ Trust & Banking's Novavax position peaked at $8.61M in Q2 2021.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.